---
title: "Sutro Biopharma (STRO.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/STRO.US/norm.md"
symbol: "STRO.US"
name: "Sutro Biopharma"
parent: "https://longbridge.com/en/quote/STRO.US.md"
datetime: "2026-05-20T14:30:32.793Z"
locales:
  - [en](https://longbridge.com/en/quote/STRO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/STRO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/STRO.US/norm.md)
---

# Sutro Biopharma (STRO.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -2.94 | -5.35 | -6.70 | -1.36 | -9.14 |
| ROE | 154.45% | 170.26% | 381.02% | 158.82% | -3234.40% |
| Revenue | 14.52M | 11.65M | 9.69M | 63.74M | 17.40M |
| Net income | -38.48M | -46.76M | -56.86M | -11.50M | -75.97M |
| Operating income | -29.61M | -33.66M | -38.90M | 15.08M | -47.47M |
| Gross margin | 100.00% | -214.60% | -311.15% | 39.88% | -196.55% |
| Net margin | -264.99% | -401.49% | -586.58% | -18.04% | -436.62% |
| Profit quality | - | - | - | -33.71% | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 241.99M | 173.83M | 209.66M | 262.36M | 321.43M |
| Leverage | -3.62 | -1.31 | -2.40 | -8.17 | -12.45 |
| BVPS | -5.11 | -15.43 | -10.25 | -3.79 | -3.06 |
| Turnover | 0.3536 | 0.3653 | 0.3194 | 0.2781 | 0.1833 |
| Cash & STI | 202.56M | 141.43M | 167.59M | 205.13M | 248.97M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 19.07M | 21.55M | 26.69M | 29.82M | 33.08M |
| Net debt | -188.93M | -125.75M | -149.93M | -185.54M | -227.57M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | -26.43M | -38.19M | -44.72M | -67.88M |
| Investing CF | - | 18.70M | 39.99M | 2.58M | -16.26M |
| Financing CF | - | -64000.00 | 102000.00 | -60000.00 | 66000.00 |
| Free CF | - | -9.50M | -11.39M | -30.65M | -34.56M |
| OCF coverage | - | -14366.85% | -15214.74% | -52004.65% | -5782.20% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | -184000.00 | -251000.00 | -86000.00 | -1.17M |